definiens: means, with respect to a particular Licensed Prod uct and country, any product that ( a)(i ) contains the same compound as the Compo und in such Licensed Product or ( ii ) is or would ot herwise qualify as a biosimilar version and/or an interchan geable version of the Licensed Product, as the term s and are used in 42 U .S.C. § 262(i)(2)-(3 ), except that in either ( i ) or ( ii ) said Generic Product may differ from the Licensed Produc t in terms of route of administration, dosage form, and strength ; ( b ) is sold under a marketing authorizati on granted by a Regulatory Authority in such countr y such as the regulatory approval processes described in in 4 2 U.S.C. § 262, including § § 262(a ) and 262(k ), or an equivalent process in any country outside the U.S., or any other equivalent provision that comes into force, in each case for an Indication for which such Licensed Product obtained Regulatory Approval in such count ry ; and ( c ) is sold in such country by a Third Party that i s not a Sublicensee of Roivant or its Affiliates an d did not obtain such product in a chain of distribution that includ es any of Roivant, its Affiliates, or Sublicensees